Pharmaceutical Executive
January 17, 2015
Features
1
Examining a new three-part formula to enable the supply chain function to manage market pressures while delivering on the bottom line.
January 13, 2015
Columns
1
In a follow-up to our November CEO profile, Novo Nordisk’s Jesper Høiland writes how pharma companies and insurers are learning to collaborate.
January 13, 2015
Columns
1
Brand success can hinge on discovering the deeper motivations of customers and addressing the cognitive biases that result.
January 12, 2015
From the Editor
1
I offered up a prediction: that the future of the biopharmaceutical business depended on how managers fared on five key measures of performance.
January 12, 2015
Features
1
Pharm Exec’s annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead.
January 12, 2015
Columns
1
The Canadian R&D industry, which boasts a rich history of drug innovation, celebrates a series of anniversaries.
January 09, 2015
Features
1
Pharm Exec profiles Sanofi EVP Pascale Witz, tagged with the assignment to move a lumbering biopharma giant closer to the embrace of the patient perspective in healthcare.
January 01, 2015
Features
1
AmerisourceBergen, big Pharma’s top distribution partner, looks to build on its US success in healthcare delivery to create a global service mix focused on knowledge transfer, scale and reach, and partnered innovation.
January 01, 2015
Special Sponsored Section
1
With spending on healthcare increasing in Malaysia, access to innovative drugs remains a challenge as the country juggles its dual public-private health system.